{"version":"1.0","type":"link","title":"Real-world safety and effectiveness of zanubrutinib vs ibrutinib in CLL: the CLL-ZANU2024 Italian cohort.","author_name":"Martino EA 외","author_url":"https://prs-insight.online/author/Martino%20EA","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/160384","thumbnail_width":1200,"thumbnail_height":630}